Gwill York - 02 Jan 2025 Form 4 Insider Report for Alto Neuroscience, Inc. (ANRO)

Role
Director
Signature
/s/ Erin R. McQuade, Attorney-in-Fact
Issuer symbol
ANRO
Transactions as of
02 Jan 2025
Transactions value $
$61,999
Form type
4
Filing time
06 Jan 2025, 16:18:22 UTC
Previous filing
07 Feb 2024
Next filing
15 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANRO Stock Option (right to buy) Award $61,998 +19,558 $3.17 19,558 02 Jan 2025 Common Stock 19,558 $4.38 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 4,889 shares underlying the option shall vest on March 31, 2025, 4,890 shares underlying the option shall vest on June 30, 2025, 4,889 shares underlying the option shall vest on September 30, 2025 and 4,890 shares underlying the option shall vest on December 31, 2025, subject to the Reporting Person's continuous service through each such vesting date.
F2 This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $62,000.